Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity

This prospective randomized comparative trial study aimed to evaluate the therapeutic outcomes of radical nephroureterectomy and adjuvant chemotherapy (ACT) used in combination in high risk upper tract urothelial carcinoma (UTUC) patients with cardiovascular comorbidity. Based on the inclusion crite...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yong, Feng, Bingfu, Wei, Dechao, Han, Yili, Li, Mingchuan, Zhao, Jiahui, Lin, Yunhua, Hou, Zhu, Jiang, Yongguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572393/
https://www.ncbi.nlm.nih.gov/pubmed/33077839
http://dx.doi.org/10.1038/s41598-020-74940-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572393/
https://www.ncbi.nlm.nih.gov/pubmed/33077839
http://dx.doi.org/10.1038/s41598-020-74940-x

Ejemplares similares